A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer
Clinical trial NCT01966471 · COMPLETED
Trial details
- NCT number
- NCT01966471
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-31
- Primary completion
- 2019-11-27
- Enrollment
- 1846
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.